Featured Articles
-
Why Trusted Data, Connected Systems, And Smart Workflows Are The Future
10/16/2026
QC labs face rising sample volumes and tighter data expectations. Automation progress depends less on robotics than on standardization, connected data, early cross-functional planning, and more.
-
Science-Driven Risk Mitigation In Single-Use Drug Product Processing
10/16/2026
Explore how extractables and leachables from single-use systems can affect peptide stability, as well as how science-led approaches to component selection can reduce risk throughout manufacturing.
-
The Critical Role Of Excipients In GLP-1 Agonist Formulation Design
10/16/2026
Excipient selection shapes GLP-1 agonist formulations, from granulated buffers to carrier-based systems aimed at improving solubility and achieving targeted release in the intestine.
-
Navigating The Analytical Challenges Of Complex ADCs
10/14/2026
Antibody drug conjugates are expanding to deliver diverse therapeutic payloads. Advanced analytical strategies are required to characterize these evolving platforms.
-
Developing Custom GMP Lipids: A Patient-Driven Partnership
10/8/2026
Custom lipid programs depend on how process development and manufacturing teams collaborate, from first design through scale-up to GMP production for LNP-based therapies.
-
Getting Started On A Successful Path To Microbial QC Automation
10/6/2026
Moving microbial QC toward automation involves team-building, facility readiness, staff concerns, validation, regulatory alignment, and cost justification that extends well beyond simple labor savings.
-
High-Performing Ionizable Lipids For Controlled Nucleic Acid Delivery
9/29/2026
Ionizable lipids are central to effective mRNA delivery, influencing potency, biodistribution, and toxicity. See why advancing delivery beyond the liver will require stronger structure-function insights.
-
Breaking The AAV Titer Barrier: A 9x Manufacturing Breakthrough
9/22/2026
See how targeted optimization of cell culture media and transfection reagents increased AAV titers ninefold while improving full capsid percentages, strengthening HEK293 production, and more.
-
Accelerating Technology Transfer Of A Drug Product
9/9/2026
See how structured testing can reduce transfer risk, confirm scalability and reuse strategies, as well as how to improve process robustness and deliver meaningful savings on chemicals and consumables.
-
A Comprehensive Solution With Targeted And Non-Targeted Approaches
8/26/2026
Explore how non-targeted NGS and targeted molecular assays can work together during cell line characterization to provide broad virus detection while supporting evolving regulatory expectations.